z-logo
Premium
Bacillus toyonensis BCT‐7112 T transient supplementation improves vaccine efficacy in ewes vaccinated against Clostridium perfringens epsilon toxin
Author(s) -
Santos F.D.S.,
Ferreira M.R.A.,
Maubrigades L.R.,
Gonçalves V.S.,
Lara A.P.S.,
Moreira C.,
Salvarani F.M.,
Conceição F.R.,
Leivas Leite F.P.
Publication year - 2021
Publication title -
journal of applied microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 156
eISSN - 1365-2672
pISSN - 1364-5072
DOI - 10.1111/jam.14814
Subject(s) - immune system , clostridium perfringens , vaccination , biology , microbiology and biotechnology , antibody , humoral immunity , immunology , genetics , bacteria
Aim The aim of the present study was to examine the vaccine immune response in ewes supplemented with Bacillus toyonensis BCT‐7112 T during a period of 5‐day supplementation before vaccination against a recombinant Clostridium perfringens epsilon toxin (rETX). Methods and Results Ewes were vaccinated with 200  µ g of rETX adjuvanted with 10% aluminium hydroxide. The treat group was orally supplemented with B. toyonensis BCT‐7112 T (3 × 10 8 viable spores) for 5 days prior to the first and second vaccination. Ewes supplemented with B. toyonensis BCT‐7112 T showed higher neutralizing antibody titres than the non‐supplemented ewes ( P <  0·05), with an increase in serum levels for total IgG anti‐rETX by 3·2‐fold ( P <  0·0001), and for both IgG isotypes IgG1 and IgG2 by 2·1‐fold and 2·3‐fold ( P <  0·01), respectively, compared with the control group. The peripheral blood mononuclear cells of ewes in the supplemented group had a higher ( P <  0·05) cytokine mRNA transcription levels for IL‐2 (6·4‐fold increase), IFN‐γ (2·9‐fold increase) and transcription factor Bcl6 (2·3‐fold increase) compared with the control group. Conclusion We conclude that a 5 days of supplementation with B. toyonensis BCT‐7112 T prior vaccination is sufficient to significantly improve the humoral immune response of ewes against C. perfringens recombinant ETX vaccine. Significance and Impact of the study These findings open a new perspective in the utilization of B. toyonensis BCT‐7112 T as an immunomodulator since a 5 days period of probiotic supplementation is sufficient to improve the vaccine immune response.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here